Shareholder Lawsuit Targets Franklin BSP Realty Trust Over Dividend Disclosure Claims

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Class action lawsuit filed against Franklin BSP Realty Trust alleging false statements about dividend sustainability. Covers investors who purchased shares November 2024-February 2026.

Shareholder Lawsuit Targets Franklin BSP Realty Trust Over Dividend Disclosure Claims

A class action lawsuit has been filed against Franklin BSP Realty Trust, Inc. (FBRT), alleging that the real estate investment trust made false and misleading statements regarding its business operations and its ability to sustain its $0.355 per share dividend distribution. The litigation covers investors who purchased FBRT shares during the period spanning November 5, 2024 through February 11, 2026.

According to the complaint, shareholders who acquired FBRT securities during this timeframe and incurred substantial losses may be eligible to participate in the class action. Legal representatives are actively seeking investors meeting these criteria to discuss potential claims. The designation of a lead plaintiff in the case is scheduled to be determined by April 27, 2026.

False disclosure claims involving dividend-paying REITs have become an area of increased shareholder litigation in recent years. Such lawsuits typically allege that companies failed to adequately disclose material information that would have affected investment decisions or dividend sustainability. Affected investors are advised to review the specific allegations and consult legal counsel regarding their eligibility and potential recovery options.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 27

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON